The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents

Clinical trial NCT02973061 · UNKNOWN

Trial details

NCT number: NCT02973061
Sponsor: Assaf-Harofeh Medical Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Growth Hormone Deficiency Attention Deficit Disorder Idiopathic Short Stature

Start date: 2015-01-01
Primary completion: 2024-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.